Ketorolac
-
Molecular Structure
Detailed Description
IUPAC NAME-(±)-5-benzoyl-2,3-dihydro-
1H-pyrrolizine-1-carboxylic acid,
2-amino-2-(hydroxymethyl)-1,3-propanediol
MOLECULAR FORMULA-C15H13NO3
MOLAR MASS-255.27 g/mol
Ketorolac is indicated for short-term management of moderate to severe pain. Concerns about the high incidence of reported side effects led to restriction in its dosage and maximum duration of use. In the UK, treatment should be initiated only in a hospital. Maximum duration of treatment should not exceed five days for tablets

- Ketorolac